The Benefits and uses of Abirapro 250mg Tablets

What is The  Abirapro 250mg Tablets?

Abirapro 250mg Tablet is utilized to treat prostate cancer. It is also used to treat other diseases according to the physician. It can be used in conjunction in conjunction with other medications in conjunction chemotherapy.

Abirapro 250 mg Tablet should not be taken with the stomach empty. Consuming it in conjunction with food could result in adverse effects. Your doctor will determine what dosage is required and the amount of time you'll need to use it. This will be based on what you're receiving treatment for, and could vary from time-to-time. It is important to follow the exact dosage that your physician has recommended. Doing it in the wrong manner or too much could cause dangerous adverse side negative effects. It could take several weeks or even months to notice or feel the benefits. However, do not stop using it unless your physician advises you to.





USES OF ABIRAPRO TABLET?

Prostate cancer

BENEFITS OF ABIRAPRO TABLET?

In Prostate cancer


Prostate glands are a tiny gland of walnut size which produces a fluid known as seminal fluid. It is a source of nourishment and moves sperms from males. The most frequent indication associated with prostate cancer are difficulty in urinary frequency, although often there is no sign whatsoever. Abirapro 250mg Tablet slows down or blocks the growth of cancerous cells by reducing the level of testosterone (natural hormone that males produce) in males. It also helps with the process of urinating and helps users to urinate.

SIDE EFFECTS OF ABIRAPRO TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
    • Edema (swelling)
    • Vomiting
    • Decreased potassium level in blood
    • Decreased white blood cell count
    • Fatigue
    • Increased liver enzymes
    • Anemia (low number of red blood cells)
    • Urinary tract infection
    • Diarrhea
    • High blood pressure
    • Cough
    • Hypercholesterolemia (high cholesterol)
    • Joint swelling
    • Increased levels of blood fat
    • Altered blood sugar level


  • HOW TO USE ABIRAPRO TABLET?

    You should take this medication according to the dose and duration recommended by your physician. Take it in a single swallow. Don't chew or crush it. Do not break it. Abirapro 250 mg Tablet is meant to be taken with a full stomach.

    HOW ABIRAPRO TABLET WORKS?

    Abirapro 250 mg Tablets are an anticancer drug. It prevents androgen (male hormone) production in humans. It does this by blocking the enzyme (CYP17) which produces androgen. This is the way it reduces the growth of prostate cancer.

  • What are the facts Of Abirapro (Abiraterone Acetate)?

  • Medicine Name: Abirapro
    Generic Name: Abiraterone Acetate
    Approval Date: 10/12/2012
    Available as (Form & Strength): 250 mg tablets
    Company Name: Glenmark Pharma


Conclusion

Please contact +91 9818274099 for Abirapro (Abiraterone Acetate) price in India

We take guarantee of quality and delivery anywhere in the world as per the buyer�s requirements.












    Location: Ghitorni, New Delhi, Delhi, India

    Comments

    Post a Comment

    Popular posts from this blog

    Treatment for Acute Myeloid Leukemia: IDHIFA (Enasidenib)

    Image
      In the world of oncology, breakthroughs in targeted therapies have opened new avenues for the treatment of various types of cancer. One such remarkable advancement is the introduction of IDHIFA (Enasidenib), a medication that has shown great promise in the fight against acute myeloidleukemia (AML) . Understanding IDHIFA and AML:  IDHIFA, known by its generic name Enasidenib, is an oral medication that targets a specific mutation known as isocitrate dehydrogenase 2 (IDH2). Mutations in the IDH2 gene are found in approximately 12-20% of AML patients. These mutations lead to the production of an abnormal form of the IDH2 enzyme, which plays a significant role in the development and progression of AML. Approved Indication: IDHIFA is specifically indicated for the treatment of adult patients with relapsed or refractory AML harboring an IDH2 mutation. It is not intended for use in patients with other types of leukemia or those without the IDH2 mutation. Accessing IDHIFA: Obtaining IDHIFA
    Read more

    What Patients Should Know about Early Access Programs- AlleviareIndia

    Image
      Introduction: In the world of medical research and development, new treatments, drugs, and therapies are constantly being developed to address various health conditions. However, the journey from initial development to final approval by regulatory authorities can be a lengthy process, leaving many patients eagerly awaiting access to potentially life-saving treatments. This is where Early Access Programs (EAPs) come into play. In this article, we will explore what patients should consider when participating in an Early Access Program. Understand the Purpose and Eligibility Criteria: Before considering participation in an Early Access Program, it's important to understand its purpose. EAPs are designed to provide access to investigational treatments for patients who have exhausted all other available options and have a serious or life-threatening condition. Familiarize yourself with the eligibility criteria to determine if you meet the necessary requirements. Discuss with
    Read more

    Abatacept (Orencia)

    Image
    Abatacept (Orencia) is often prescribed after failure of an anti-rheumatic agent (DMARD), such as methotrexate. But it can be used as first-line therapy. Ebetasip is used to reduce inflammatory symptoms such as swelling, pain, and stiffness. In the long term, it is expected to prevent joint deformity, therefore helping to maintain range of motion. It is often used in patients with moderate to severe rheumatoid arthritis who have not responded to one or more DMARDs, such as methotrexate, or other biologic drugs. DMARDs are usually tried first. Abatacept may be used alone or in combination with DMARDs, which makes it more potent, but not with other biologic drugs (such as TNF inhibitors). Its use in other diseases is still being studied. Unlike some other biologic drugs, abetacept does not block anti-inflammatory proteins such as TNF-alpha antagonists. Abatacept attaches to the surface of inflammatory cells and blocks communication between these cells. By blocking this communicatio
    Read more